CSIMarket Company Name, Ticker, Customers, else..
 
Singular Genomics Systems Inc   (NASDAQ: OMIC)
 
Price: $20.0100 $0.05 0.251%
Day's High: $20.01 Week Perf: 0.35 %
Day's Low: $ 19.96 30 Day Perf: 1.57 %
Volume (M): 7,900 52 Wk High: $ 0.00
Volume (M$): $ 158 52 Wk Avg: $0.00
Open: $20.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) 50
 Shares Outstanding (Millions) 3
 Employees 190
 Revenues (TTM) (Millions $) 3
 Net Income (TTM) (Millions $) -86
 Cash Flow (TTM) (Millions $) 18
 Capital Exp. (TTM) (Millions $) 0

Business Description


Singular Genomics Systems Inc. is a biotechnology company that specializes in single-cell genomics technology. The company develops and commercializes innovative solutions for the analysis of individual cells with the goal of understanding the genetic makeup and functionality of diverse cell populations. Their technology allows researchers and scientists to study and analyze genetic information at the single-cell level, providing valuable insights into complex biological systems and diseases. Singular Genomics Systems Inc. aims to contribute to advancements in precision medicine, drug discovery, and various areas of life science research.


   Company Address: 3010 Science Park Road San Diego 92121 CA
   Company Phone Number: 333-7830   Stock Exchange / Ticker: NASDAQ OMIC


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
A   -1.94%    
AVTR        2.67% 
BRKR        2.49% 
ILMN        1.22% 
MTD   -3.81%    
RVTY        1.1% 
• View Complete Report
   



Merger and Acquisition

“Singular Genomics Takes a Bold Leap Forward: Acquisition by Deerfield Management Fuels New Era of Genomic Innovation”,

Published Fri, Feb 21 2025 2:57 PM UTC

Singular Genomics Systems, Inc.: A Transformational Shift in the Genomics Landscape Following Acquisition by Deerfield ManagementSAN DIEGO, Feb. 21, 2025 — Singular Genomics Systems, Inc. (Nasdaq: OMIC), a trailblazer in the field of next-generation sequencing (NGS) and spatial multiomics technologies, has announced today the closing of its acquisition by an affiliate of D...
Stock Market Announcement

Singular Genomics Weighs Acquisition Bids from Concentra Biosciences and Deerfield Management Amid Variable Market Dynamics,

Published Thu, Sep 19 2024 9:25 PM UTC

SAN DIEGO, Sept. 19, 2024 Singular Genomics Systems, Inc. (Nasdaq: OMIC), a pioneering company in the realm of next-generation sequencing (NGS) and spatial multiomics technologies aimed at empowering researchers and clinicians, has found itself at the center of acquisition interest from prominent biosciences firms. The company announced today that it has received an unsoli...
Stock Market Announcement

Singular Genomics Thrives, Meets Nasdaq Compliance and Implements Reverse Stock Split

Published Mon, Jul 15 2024 8:05 PM UTC

Singular Genomics Regains Compliance with Nasdaq Minimum Bid Price Requirement
SAN DIEGO, July 15, 2024 - Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company specializing in next-generation sequencing and spatial multiomics technologies, announced today that it has regained compliance with Nasdaq s minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) ...
Stocks on the Move

Singular Genomics Systems Inc Trails Market Performance Amidst Trade Tensions and Financial Results Disappointment

Published Tue, Jul 2 2024 3:06 PM UTC

In this week s analysis, Singular Genomics Systems Inc (NASDAQ: OMIC) has witnessed underwhelming performance compared to the broader market. Several factors have contributed to this trend, including trade tensions affecting the EV market and disappointing financial results.Singular Genomics Systems Inc (NASDAQ: OMIC) stands out this week as its shares are trailing the overa...
Shares

Singular Genomics Systems Inc. Implements 1-for-30 Reverse Stock Split to Potentially Enhance Shareholder Value

Published Fri, Jun 21 2024 8:05 PM UTC


Singular Genomics Systems Inc. Announces 1-for-30 Reverse Stock Split
Singular Genomics Systems Inc., a company specialized in next-generation sequencing (NGS) and spatial multiomics technologies, has recently made a significant announcement. On June 26, 2024, the company will execute a 1-for-30 reverse split of its common stock. This decision will come into effect ...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 18.77
Price to Sales (Expected) -
Price to Book 0.41
PEG (TTM) -

Financial Strength Current
Quick Ratio 9.38
Working Capital Ratio 10.69
Leverage Ratio (MRQ) 0.15
Total Debt to Equity 0.04
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -15.95 $
Revenues (TTM) 1.07 $
Cash Flow (TTM) 7.28 $
Cash 45.51 $
Book Value 49.28 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 14,032
Net Income per Employee (TTM) -454,326
Receivable Turnover Ratio (TTM) 8.05
Inventory Turnover Ratio (TTM) 0.31
Asset Turnover Ratio (TTM) 0.01

Profitability Ratios Current
Gross Margin (MRQ) -74.14 %
Operating Margin (MRQ) -4450.99 %
Net Margin (MRQ) -4136.7 %
Net Cash Flow Margin (MRQ) 5543.1 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.